Bactana Animal Health Receives Patent Notice of Allowance

Posted by | No Tags | News | No Comments on Bactana Animal Health Receives Patent Notice of Allowance

Patent covers core product discovery made at Cornell University

New Canaan, CT,  April 6, 2017 – Bactana Animal Health, a company developing sustainable products aimed at reducing the use of antibiotics and hormones in the world’s food supply through immunomodulation and enhancement of the gut microbiota, today announced that Cornell University was issued a notice of allowance for U.S. Patent No. 14/380,881 entitled “Probiotic Compositions And Methods.” Bactana holds the exclusive worldwide license to this invention, which is the foundation of the company’s FPS-4™ product platform that was initially developed at Cornell University.

Read More